Sutab
Payments companies reported to CMS as associated with Sutab. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Sutab, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Sutab
These are the largest totals companies reported as associated with Sutab. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Julia Liu | Atlanta, GA | Gastroenterology (Internal Medicine) | $50,000.00 |
| Vani Konda | Dallas, TX | Gastroenterology (Internal Medicine) | $3,868.88 |
| Sravanthi Parasa | Seattle, WA | Gastroenterology (Internal Medicine) | $3,850.00 |
| Gene Chang | Munster, IN | Gastroenterology (Internal Medicine) | $3,264.62 |
| Rajiv Chhabra | Kansas City, MO | Gastroenterology (Internal Medicine) | $3,150.00 |
| Donald Campbell | Lexington, KY | Gastroenterology (Internal Medicine) | $2,200.00 |
| Jianhua Tau | Austin, TX | Gastroenterology (Internal Medicine) | $2,200.00 |
| Douglas Rex | Indianapolis, IN | Gastroenterology (Internal Medicine) | $2,000.00 |
| Jonathan Cohen | New York, NY | Gastroenterology (Internal Medicine) | $1,816.76 |
| Ramprasad Jegadeesan | Alpharetta, GA | Gastroenterology (Internal Medicine) | $1,653.30 |
Prescribed Sutab?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.